Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueShares Outstanding (Weighted Average)
Others
Ratios

Genoil (GNOLF) Shares Outstanding (Weighted Average) (2020 - 2025)

Historic Shares Outstanding (Weighted Average) for Genoil (GNOLF) over the last 7 years, with Q3 2025 value amounting to $2.0 billion.

  • Genoil's Shares Outstanding (Weighted Average) rose 236.28% to $2.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 billion, marking a year-over-year increase of 236.28%. This contributed to the annual value of $1.9 billion for FY2024, which is 6401.13% up from last year.
  • Latest data reveals that Genoil reported Shares Outstanding (Weighted Average) of $2.0 billion as of Q3 2025, which was up 236.28% from $2.0 billion recorded in Q2 2025.
  • In the past 5 years, Genoil's Shares Outstanding (Weighted Average) registered a high of $2.0 billion during Q3 2025, and its lowest value of $600.4 million during Q1 2021.
  • Over the past 5 years, Genoil's median Shares Outstanding (Weighted Average) value was $714.6 million (recorded in 2023), while the average stood at $1.2 billion.
  • In the last 5 years, Genoil's Shares Outstanding (Weighted Average) surged by 17341.66% in 2024 and then soared by 236.28% in 2025.
  • Quarter analysis of 5 years shows Genoil's Shares Outstanding (Weighted Average) stood at $618.1 million in 2021, then rose by 8.36% to $669.8 million in 2022, then surged by 76.56% to $1.2 billion in 2023, then skyrocketed by 64.01% to $1.9 billion in 2024, then increased by 3.0% to $2.0 billion in 2025.
  • Its Shares Outstanding (Weighted Average) was $2.0 billion in Q3 2025, compared to $2.0 billion in Q2 2025 and $2.0 billion in Q1 2025.